Harrington Discovery Institute

Harrington Discovery Institute

Overview

The Harrington Discovery Institute, part of The Harrington Project for Discovery & Development at University Hospitals in Cleveland, Ohio, is a non-profit medical institute with a mission to accelerate promising scientific discoveries into medicines. Established in 2012, it utilizes a blended non-profit/for-profit model to support physician-scientists by providing grant funding and expert guidance to bridge the gap between laboratory research and commercialization. It invests in and helps develop new treatments for a range of diseases, with a focus on unmet needs. The institute has an Investment Advisory Board and partners with for-profit entities, such as the Advent-Harrington Impact Fund and BioMotiv, to advance its portfolio projects toward clinical trials and commercialization.

Portfolio Companies

4

Investments

CompanyDateStageLead
Allyx Therapeutics, Inc.May 2026Series ACo-investor
EpitopOct 2024VC RoundCo-investor
PIC TherapeuticsOct 2022Series ACo-investor
EpitopApr 2022SeedCo-investor
Allyx Therapeutics, Inc.Jun 2021Series ACo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersCleveland, Ohio
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.